Stocktoria
Bausch Health Companies Inc. BHC
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 1994-09-20
Bausch Health Companies Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% |
| Net margin | 1.5% | -0.5% | -6.8% | -2.8% | -11.2% |
| FCF margin | 9.8% | 13.1% | 9.3% | -11.6% | 13.7% |
| Return on assets | 0.6% | -0.2% | -2.2% | -0.9% | -3.2% |
| Return on equity | -28.3% | 3.6% | 57.9% | 32.5% | 894.3% |
| Debt / equity | -37.58× | -16.90× | -21.91× | -30.01× | -213.72× |
| Current ratio | 1.47 | 0.86 | 1.30 | 1.08 | 1.08 |
| Revenue growth | 6.7% | 9.9% | 7.8% | -3.7% | 5.1% |
Source: SEC EDGAR filings · CIK 0000885590 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.